首页> 外文期刊>Open Journal of Nephrology >A Retrospective Quality Study of Hemodialysis Catheter-Related Bacteremia in a Danish Hospital
【24h】

A Retrospective Quality Study of Hemodialysis Catheter-Related Bacteremia in a Danish Hospital

机译:丹麦医院血液透析相关细菌血症的回顾性质量研究

获取原文
获取外文期刊封面目录资料

摘要

Background: Hemodialysis catheter-related bacteremia (HD CRB) is a major complication of long-term hemodialysis (HD) therapy and bacteremia is secondary only to cardiovascular disease as the leading cause of death in patients receiving renal replacement therapy. A large part may be preventable and surveillance is a critical aspect of infection control and prevention. Aim: To analyze incidence, causative species, and treatment of HD CRB in adult chronic HD patients at Nordsjaellands Hospital (NOH), Denmark. Methods: All episodes of bacteremia in the Department of Cardiology, Nephrology and Endocrinology (KNEA), NOH from 2010 to 2013 were analyzed. Inclusion criteria: Adult chronic HD patients with a tunneled dialysis catheter diagnosed with HD CRB. Causative microorganism and antimicrobial treatment were recorded for each episode. Findings: Ninetynine episodes of HD CRB in 72 patients were found with a mean incidence rate of 0.9/1000 catheter-days. Gram-positive bacteria were isolated in 71% of the episodes, gram-negative bacteria in 25%, both in 3%, and yeast in 1%. The most frequently isolated microorganisms were Staphylococcus aureus (33%), Coagulase-negative staphylococci (29%), enterobacteriaceae (20%) and enterococci (8%). The most commonly used empiric antimicrobials were cefuroxime and vancomycin and the overall efficacy was 77%. Conclusion: The well-functioning infection prevention strategy seems to be successful resulting in a relatively low incidence rate of HD CRB compared with that shown in international studies. The high proportion of gram-negative bacteria raises the question as to whether future antimicrobial guidelines should cover both gram-positive and gram-negative bacteria.
机译:背景:血液透析导管相关菌血症(HD CRB)是长期血液透析(HD)治疗的主要并发症,菌血症仅次于心血管疾病,是接受肾脏替代疗法的患者的主要死亡原因。很大一部分是可以预防的,监视是控制和预防感染的关键方面。目的:分析丹麦Nordsjaellands医院(NOH)的成人慢性HD患者中HD CRB的发生率,病因种类和治疗方法。方法:分析了2010年至2013年美国国家卫生部心血管内科(KNEA)的所有菌血症事件。纳入标准:成人慢性HD患者,其带有经导管透析的导管被诊断为HD CRB。记录每次发作的致病微生物和抗菌治疗。结果:发现72例HD CRB发生了90例心力宁发作,平均发生率为0.9 / 1000导管日。革兰氏阳性菌占71%,革兰氏阴性菌占25%,两者均占3%,酵母菌占1%。最常见的微生物是金黄色葡萄球菌(33%),凝固酶阴性葡萄球菌(29%),肠杆菌科(20%)和肠球菌(8%)。最常用的经验性抗菌药物是头孢呋辛和万古霉素,总疗效为77%。结论:与国际研究相比,预防感染的策略运作良好,导致HD CRB的发生率相对较低。较高的革兰氏阴性菌比例提出了一个问题,即未来的抗菌药物指南是否应同时涵盖革兰氏阳性菌和革兰氏阴性菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号